Polycystic ovary syndrome

Area of Science:

• Endocrinology
• Reproductive Medicine
• Metabolic Disorders

Background:

• Polycystic ovary syndrome (PCOS) affects 5-20% of reproductive-age women globally.
• Key features include hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology (PCOM).
• Most affected individuals exhibit metabolic dysfunction, insulin resistance, and hyperinsulinemia.

Purpose of the Study:

• To provide a comprehensive overview of PCOS, covering epidemiology, pathophysiology, diagnosis, and management.
• To summarize current knowledge and highlight future research directions for PCOS.
• To emphasize the importance of individualized treatment strategies for PCOS patients.

Main Methods:

• This primer synthesizes current scientific literature and clinical guidelines on PCOS.
• It reviews established diagnostic criteria and emerging pathophysiological insights.
• Management strategies discussed include lifestyle modifications, pharmacotherapy, and surgical interventions.

Main Results:

• PCOS is linked to increased risks of type 2 diabetes, cardiovascular events, and endometrial cancer.
• Diagnosis relies on excluding other conditions and identifying specific clinical and biochemical markers.
• Effective management requires a multi-faceted approach addressing hormonal, metabolic, and psychological aspects.

Conclusions:

• PCOS is a complex disorder with significant long-term health implications.
• Personalized management plans are essential for addressing diverse patient needs and preventing complications.
• Further research is needed to elucidate underlying mechanisms and develop novel therapeutic strategies for PCOS.